Silverwood Partners
  • About Us
    • Overview
    • Why Silverwood?
    • Careers
    • Our Location
    • Connect With Us
  • Insights & Analysis
    • Newsletters
    • Intelligence Briefs
    • Events
    • Connect With Us
  • Team
    • All Team
    • Technology
    • Consumer
    • Healthcare
  • Industry Experience
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
  • Services
    • Mergers & Acquisitions
    • Private Placements
    • Connect With Us
  • Transactions
    • All Transactions
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
Select Page
Healthcare Private Placement and M&A Transactions Review Week Ending May 25, 2025

Healthcare Private Placement and M&A Transactions Review Week Ending May 25, 2025

by Jonathan Hodson-Walker | May 29, 2025 | Healthcare

Strategy | Financing | Macro & Markets Private Placement / Financing Transactions CellCentric: The company raised $120 million of Series C venture funding in a deal led by RA Capital Management and Forbion on May 19, 2025. Avego Management and BrightEdge also...
Healthcare Private Placement and M&A Transactions Review Week Ending May 18, 2025

Healthcare Private Placement and M&A Transactions Review Week Ending May 18, 2025

by Jonathan Hodson-Walker | May 22, 2025 | Healthcare

Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Pathos: The company raised $365 million of Series D venture funding from undisclosed investors on May 15, 2025, putting the company’s pre-money valuation at $1.24 billion. The...
Healthcare Private Placement and M&A Transactions Review Week Ending May 4, 2025

Healthcare Private Placement and M&A Transactions Review Week Ending May 4, 2025

by Jonathan Hodson-Walker | May 8, 2025 | Healthcare

Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Pathos: The company raised $283 million of venture funding from undisclosed investors on May 1, 2025. The company is a developer of a drug discovery platform intended to reduce the...
Healthcare Private Placement and M&A Transactions Review Week Ending April 27, 2025

Healthcare Private Placement and M&A Transactions Review Week Ending April 27, 2025

by Jonathan Hodson-Walker | May 1, 2025 | Healthcare

Strategy | Financing | Macro & Markets Private Placement / Financing Transactions SHINE Technologies: The company received $122.5 million of development capital from undisclosed investors on April 21, 2025. The company is a developer of medical isotopes designed...
Healthcare Private Placement and M&A Transactions Review Week Ending April 20, 2025

Healthcare Private Placement and M&A Transactions Review Week Ending April 20, 2025

by Jonathan Hodson-Walker | Apr 24, 2025 | Healthcare

Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Glycomine: The company raised $115 million of Series C venture funding in a deal led by Advent Life Sciences and CTI Life Sciences Fund on April 16, 2025. Chiesi Ventures, Novo...
Healthcare Private Placement and M&A Transactions Review Week Ending April 13, 2025

Healthcare Private Placement and M&A Transactions Review Week Ending April 13, 2025

by Jonathan Hodson-Walker | Apr 16, 2025 | Healthcare

Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Merida Biosciences: The company raised $121 million of Series A venture funding in a deal led by Bain Capital Life Sciences, Third Rock Ventures and BVF Partners on April 8, 2025. GV...
« Older Entries

Search

Recent Posts

  • Technology Private Placement and M&A Transactions Review Week Ending May 25, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending May 25, 2025
  • Healthcare Private Placement and M&A Transactions Review Week Ending May 25, 2025
  • Technology Private Placement and M&A Transactions Review Week Ending May 18, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending May 18, 2025

Categories

Archives